The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Romashchenko P.N.

Kirov Military Medical Academy

Fekliunin A.A.

S.M. Kirov Military Medical Academy

Maistrenko N.A.

Kirov Military Medical Academy

Filin A.A.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

Omran V.S.

S.M. Kirov Military Medical Academy

Zherebtsov E.S.

S.M. Kirov Military Medical Academy

Trans-papillary endoscopic surgery: predictors of complications and prevention of their development

Authors:

Romashchenko P.N., Fekliunin A.A., Maistrenko N.A., Filin A.A., Omran V.S., Zherebtsov E.S.

More about the authors

Journal: Endoscopic Surgery. 2021;27(1): 40‑48

DOI: 10.17116/endoskop20212701140

Read: 1918 times

Download PDF (RU)
Contact the author
Table of contents

TRANS-PAPILLARY ENDOSCOPIC SURGERY: PREDICTORS OF COMPLICATIONS AND PREVENTION OF THEIR DEVELOPMENT
TRANS-PAPILLARY ENDOSCOPIC SURGERY: PREDICTORS OF COMPLICATIONS AND PREVENTION OF THEIR DEVELOPMENT

To cite this article:

Romashchenko PN, Fekliunin AA, Maistrenko NA, Filin AA, Omran VS, Zherebtsov ES. Trans-papillary endoscopic surgery: predictors of complications and prevention of their development. Endoscopic Surgery. 2021;27(1):40‑48. (In Russ.)
https://doi.org/10.17116/endoskop20212701140

Подписка 2025-2 (Endoscopic Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata
Recommended articles:
Prediction and prevention of fascial dehi­scence after lapa­rotomy. Piro­gov Russian Journal of Surgery. 2025;(1):47-53
Late complications and quality of life after multivisceral surgeries with pancreatoduodenectomy. Piro­gov Russian Journal of Surgery. 2025;(7):36-45

Trans-papillary endoscopic management has become the «gold standard» for patients with benign and malignant biliopancreatic diseases. Despite the rather low incidence of postoperative complications and rare mortality in comparison with traditional surgery, trans-papillary endoscopic management should be performed by highly qualified specialists, as this becomes a necessary condition for improving the effectiveness and safety of minimally invasive treatment, especially for patients with high surgery and anesthetic risks. The article describes the complications of trans-papillary endoscopic management, analyzes the risk factors and methods for their prevention.

Keywords:

trans-papillary endoscopic surgery
complications of EST
post-operative pancreatitis
papillotomy bleeding
duodenum perforation
acute cholangitis
prevention of complications

Authors:

Romashchenko P.N.

Kirov Military Medical Academy

Fekliunin A.A.

S.M. Kirov Military Medical Academy

Maistrenko N.A.

Kirov Military Medical Academy

Filin A.A.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

Omran V.S.

S.M. Kirov Military Medical Academy

Zherebtsov E.S.

S.M. Kirov Military Medical Academy

Received:

13.06.2020

Accepted:

26.10.2020

List of references:

  1. Cotton PB, Garrow DA, Gallagher J, Romagnuolo J. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc. 2009;70:80-88.  https://doi.org/10.1016/j.gie.2008.10.039
  2. Rustagi T, Jamidar PA. Endoscopic retrograde cholangiopancreatography-related adverse events: general overview. Gastrointest Endosc Clin N Am. 2015;25:97-106.  https://doi.org/10.1016/j.giec.2014.09.005
  3. Glomsaker T, Hoff G, Kvaløy JT, Søreide K, Aabakken L, Søreide J. A. Patterns and predictive factors of complications after endoscopic retrograde cholangiopancreatography. Br J Surg. 2013;100:373-380.  https://doi.org/10.1002/bjs.8992
  4. Ryozawa S, Itoi T, Katanuma A. Japan Gastroenterological Endoscopy Society guidelines for endoscopic sphincterotomy. Digest Endosc. 2018;30:149-173.  https://doi.org/10.1111/den.13001
  5. Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D, Bruining DH, Eloubeidi MA, Fanelli RD, Faulx AL, Gurudu SR, Kothari S, Lightdale JR, Qumseya BJ, Shaukat A, Wang A, Wani SB, Yang J, DeWitt JM. Adverse events associated with ERCP. Gastrointest Endosc. 2017;85(1):32-47.  https://doi.org/10.1016/j.gie.2016.06.051
  6. Dumonceau J-M, Kapral C, Aabakken L, Papanikolaou IS, Tringali A, Vanbiervliet G, Beyna T, Dinis-Ribeiro M, Hritz I, Mariani A, Paspatis G, Radaelli F, Lakhtakia S, Veitch AM, van Hooft JE. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2020;52(02):127-149.  https://doi.org/10.1055/a-1075-4080
  7. Freeman ML. Complications of endoscopic retrograde cholangiopancreatography: Avoidance and management. Gastrointest Endosc Clin N Am. 2012;22:567-586.  https://doi.org/10.1016/j.giec.2012.05.001
  8. Fedorov AG, Davydov SV, Klimov AE. Oslozhnenija jendoskopicheskih transpapilljarnyh vmeshatel’stv i sposoby ih profilaktiki i lechenija. Obzor literatury. Neotlozhnaya medicinskaya pomoshh’. 2012;3:29-35. (In Russ.). https://doi.org/10.17116/endoskop201521216-19
  9. Pryadko AS, Maistrenko NA, Romashchenko PN, Boiko IYu. Endoskopicheskie i punktsionnye metodiki v diagnostike i lechenii khronicheskogo pankreatita. Vestnik neotlozhnoi i vosstanovitel’noi meditsiny. 2013;14(4):493-498. (In Russ.). https://doi.org/10.24884/0042-4625-2015-174-5-22-31
  10. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RCG, Meyers WC, Liguory C, Nickl N. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383-393.  https://doi.org/10.1016/s0016-5107(91)70740-2
  11. Dumonceau J-M, Andriulli A, Elmunzer BJ, Mariani A, Meister T, Deviere J, Marek T, Baron TH, Hassan C, Testoni PA, Kapral C. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline — updated June 2014. Endoscopy. 2014;46:799-815.  https://doi.org/10.1055/s-0034-1377875
  12. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS. Classification of acute pancreatitis — 2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102-111.  https://doi.org/10.1136/gutjnl-2012-302779
  13. Beburishvili AG, Zyubina EN, Turovets MI, Mandrikov VV. Metody profilaktiki razvitiya ostrogo pankreatita posle endoskopicheskikh transpapillyarnykh vmeshatel’stv. Khirurgiya. Zhurnal im. N.I. Pirogova. 2015;21(3):24-29. (In Russ.). https://doi.org/10.17116/endoskop201521324-29
  14. Ding X, Zhang F, Wang Y. Risk factors for post-ERCP pancreatitis: A systematic review and meta-analysis. Surgeon. 2015;13:218-229.  https://doi.org/10.1016/j.surge.2014.11.005
  15. Kochar B, Akshintala VS, Afghani E, Elmunzer BJ, Kim KJ, Lennon AM, Khashab MA, Kalloo AN, Singh VK. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endoscopy. 2015;81:143-159.  https://doi.org/10.1016/j.gie.2014.06.045
  16. Shapoval’janc SG, Gabrijel’ SA, Dyn’ko VJu, Kotieva AJu, Mamishev AK, Bespechnyj MV. Ostryi postmanipulyacionnyi pankreatit: diagnostika, faktory riska, sposoby profilaktiki. Endoskopicheskaya hirurgiya. 2020;26(4):49-53. (In Russ.). https://doi.org/10.17116/endoskop20202604149
  17. Halttunen J, Meisner S, Aabakken L, Arnelo U, Grönroos J, Hauge T, Kleveland PM, Schmidt PN, Saarela A, Swahn F, Toth E, Mustonen H, Löhr J-M. Difficult cannulation as defined by a prospective study of the Scandinavian Association for Digestive Endoscopy (SADE) in 907 ERCPs. Scand J Gastroenterol. 2014;49:752-758.  https://doi.org/10.3109/00365521.2014.894120
  18. Feng Y, Zhu H, Chen X, Xu S, Cheng W, Ni J, Shi R. Comparison of endoscopic papillary large balloon dilation and endoscopic sphincterotomy for retrieval of choledocholithiasis: a meta-analysis of randomized controlled trials. J Gastroenterol. 2012;47:655-663.  https://doi.org/10.1007/s00535-012-0528-9
  19. Mariani A, Giussani A, Di Leo M, Testoni S, Testoni PA. Guidewire biliary cannulation does not reduce post-ERCP pancreatitis compared with the contrast injection technique in low-risk and high-risk patients. Gastrointest Endosc. 2012;75:339-346.  https://doi.org/10.1016/j.gie.2011.09.002
  20. Tse F, Yuan Y, Moayyedi P, Leontiadis G. Guide wire-assisted cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 2013;45:605-618.  https://doi.org/10.1055/s-0032-1326640
  21. Cennamo V, Fuccio L, Zagari RM, Eusebi LH, Ceroni L, Laterza L, Fabbri C, Bazzoli F. Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis? A meta-analysis of randomized controlled trials. Am J Gastroenterol. 2009;104:2343-2350. https://doi.org/10.1038/ajg.2009.269
  22. Kobayashi G, Fujita N, Imaizumi K, Irisawa A, Suzuki M, Murakami A, Oana S, Makino N, Komatsuda T, Yoneyama K. Wire-guided biliary cannulation technique does not reduce the risk of post-ERCP pancreatitis: Multicenter randomized controlled trial. Dig Endosc. 2013;25:295-302.  https://doi.org/10.1111/j.1443-1661.2012.01372.x
  23. Mazaki T, Mado K, Masuda H, Shiono M. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis. J Gastroenterol. 2014;49:343-355.  https://doi.org/10.1007/s00535-013-0806-1
  24. Nakai Y, Isayama H, Sasahira N, Kogure H, Sasaki T, Yamamoto N, Saito K, Umefune G, Akiyama D, Kawahata S, Matsukawa M, Saito T, Hamada T, Takahara N, Mizuno S, Miyabayashi K, Mohri D, Hirano K, Tada M, Koike K. Risk factors for post-ERCP pancreatitis in wire-guided cannulation for therapeutic biliary ERCP. Gastrointest Endosc. 2015;81:119-126.  https://doi.org/10.1016/j.gie.2014.06.005
  25. Cha S-W, Leung WD, Lehman GA, Watkins JL, McHenry L, Fogel EL, Sherman S. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study. Gastrointest Endosc. 2013;77:209-216.  https://doi.org/10.1016/j.gie.2012.08.022
  26. Choksi N.S, Fogel EL, Cote GA, Romagnuolo J, Elta GH, Scheiman JM, Chak A, Mosler P, Higgins PDR, Korsnes SJ, Schmidt SE, Sherman S, Lehman GA, Elmunzer BJ. The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement. Gastrointest Endosc. 2015;81:150-155.  https://doi.org/10.1016/j.gie.2014.07.033
  27. Conigliaro R, Manta R, Bertani H, Manno M, Barbera C, Caruso A, Olivetti G, Melotti G, Frazzoni M. Pancreatic duct stenting for the duration of ERCP only does not prevent pancreatitis after accidental pancreatic duct cannulation: A prospective randomized trial. Surg Endosc. 2013;27:569-574.  https://doi.org/10.1007/s00464-012-2487-x
  28. Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology. 1998;115:1518-1524. https://doi.org/10.1016/s0016-5085(98)70031-9
  29. Freeman ML. Pancreatic stents for prevention of postendoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2007;5:1354-1365. https://doi.org/10.1016/j.cgh.2007.09.007
  30. Elmunzer BJ, Scheiman JM, Lehman GA. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366:1414-1422. https://doi.org/10.1056/nejmc1205928
  31. Ding X, Chen M, Huang S, Zhang S, Zou X. Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis. Gastrointest Endosc. 2012;76:1152-1159. https://doi.org/10.1016/j.gie.2012.08.021
  32. Puig I, Calvet X, Baylina M, Isava Á, Sort P, Llaó J, Porta F, Vida F. How and when should NSAIDs be used for preventing post-ERCP pancreatitis? A systematic review and meta-analysis. PLoS One. 2014;9:11-18.  https://doi.org/10.1371/journal.pone.0092922
  33. Akbar A, Abu Dayyeh BK, Baron TH, Wang Z, Altayar O, Murad MH. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis. Clin Gastroenterol Hepatol. 2013;11:778-783.  https://doi.org/10.1016/j.cgh.2012.12.043
  34. Elmunzer BJ, Higgins PDR, Saini SD, Scheiman JM, Parker RA, Chak A, Romagnuolo J, Mosler P, Hayward RA, Elta GH, Korsnes SJ, Schmidt SE, Sherman S, Lehman GA, Fogel EL. Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. Am J gastroenterol. 2013;108:410-415.  https://doi.org/10.1038/ajg.2012.442
  35. Buxbaum J, Yan A, Yeh K, Lane C, Nguyen N, Laine L. Aggressive hydration with lactated Ringer’s solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol. 2014;12:303-307.  https://doi.org/10.1016/j.cgh.2013.07.026
  36. Shaygan-Nejad A, Masjedizadeh AR, Ghavidel A, Ghojazadeh M, Khoshbaten M. Aggressive hydration with Lactated Ringer’s solution as the prophylactic intervention for postendoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled double-blind clinical trial. J Res Med Sci. 2015;20:838-843.  https://doi.org/10.4103/1735-1995.170597
  37. Wu BU, Hwang JQ, Gardner TH, Repas K, Delee R, Yu S, Smith B, Banks PA, Conwell DL. Lactated Ringer’s solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011;9:710-717.  https://doi.org/10.1016/j.cgh.2011.04.026
  38. Alberca-de-las-Parras F, Egea-Valenzuela J, Carballo-Alvarez F. Bleeding risk in endoscopic retrograde cholangiopancreatography. Impact of the use of antithrombotic drugs. Rev Esp Enferm Dig. 2016;109(3):202-210.  https://doi.org/10.17235/reed.2017.4358/2016
  39. Park DH, Kim MH, Lee SK, Lee SS, Choi JS, Song MH, Seo DW, Min YI. Endoscopic sphincterotomy vs. endoscopic papillary balloon dilation for choledocholithiasis in patients with liver cirrhosis and coagulopathy. Gastrointest Endosc. 2004;60:180-185.  https://doi.org/10.1016/s0016-5107(04)01554-8
  40. Tsujino T, Isayana H, Komatsu Y, Ito Y, Tada M, Minagawa N, Nakata R, Kawabe T, Omata M. Risk factors for pancreatitis in patients with common bile duct stones managed by endoscopic papillary balloon dilation. Am J Gastroenterol. 2005;100:38-42.  https://doi.org/10.1111/j.1572-0241.2005.40638.x
  41. Matsushita M, Takakuwa H, Shimeno N, Uchida K, Nishio A, Okazaki K. Prophylactic injection of hypertonic saline-epinephrine oral to the papilla for prevention of postsphincterotomy bleeding. J Clin Gastroenterol. 2010;44:167-170.  https://doi.org/10.1097/mcg.0b013e3181e5ceca
  42. Morgan KA, Fontenot BB, Ruddy JM, Mickey S, Adams DB. Endoscopic retrograde cholangiopancreatography gut perforations: when to wait! When to operate! Am Surg. 2009;75:477-483.  https://doi.org/10.1002/9781444300123.ch49
  43. Cotton PB, Connor P, Rawls E, Romagnuolo J. Infection after ERCP and antibiotic prophylaxis: a sequential quality-improvement approach over 11 years. Gastrointest Endosc. 2008;67:471-475.  https://doi.org/10.1016/j.gie.2007.06.065
  44. Bangarulingam SY, Gossard AA, Petersen BT, Ott BJ, Lindor KD. Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis. Am J Gastroenterol. 2009;104:855-860.  https://doi.org/10.1038/ajg.2008.161
  45. Khashab MA, Chithadi KV, Acosta RD, Bruining DH, Chandrasekhara V, Eloubeidi MA, Fanelli RD, Faulx AL, Fonkalsrud L, Lightdale JR, Raman Muthusamy V, Pasha SF, Saltzman JR, Shaukat A, Wang A, Cash BD. ASGE Standards of Practice Committee. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2015;81:81-89.  https://doi.org/10.1016/j.gie.2014.08.008
  46. Sawas T, Al Halabi S, Parsi MA, Vargo JJ. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc. 2015;82:256-267.  https://doi.org/10.1016/j.gie.2015.03.1980
  47. Costamagna G, Boskoski I. Current treatment of benign biliary strictures. Ann Gastroenterol. 2013;26:37-40.  https://doi.org/10.1016/b978-0-323-48109-0.00043-2
  48. Pfau PR, Pleskow DK, Banerjee S, Barth BA, Bhat YM, Desilets DJ, Gottlieb KT, Maple JT, Siddiqui UD, Tokar JL, Wang A, Song L-MWK, Rodriguez SA. ASGE Technology Committee. Pancreatic and biliary stents. Gastrointest Endosc. 2013;77:319-327.  https://doi.org/10.1016/j.gie.2012.09.026

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.